Biogen Inc.
BIIB· Nasdaq
BIIBBiogen Inc.
Quarterly figures for Biogen Inc., with source filings when available.
69 quarters. Jun 30, 2008 to Jun 30, 2026. USD.
Biogen Inc. has filed its 10-Q within 24 to 32 days of period end across its last 8 quarters. The 10-K runs 34 to 46 days.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 29, 2026 · pre-market | Jul 29, 2026 | 29 d | 10-Q | $2.74B | +3.4% | $0.66 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| Apr 29, 2026 · pre-market |
| Apr 29, 2026 |
| 29 d |
| 10-Q |
| $2.48B |
| +1.9% |
| $2.15 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 6, 2026 · pre-market | Feb 6, 2026 | 37 d | 10-K | $2.28B | −7.1% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 30, 2025 · pre-market | Oct 30, 2025 | 30 d | 10-Q | $2.53B | +2.8% | $3.17 | |
| Q2 2025 | Jun 30, 2025 | Jul 31, 2025 · pre-market | Jul 31, 2025 | 31 d | 10-Q | $2.65B | +7.3% | $4.33 | |
| Q1 2025 | Mar 31, 2025 | May 1, 2025 · pre-market | May 1, 2025 | 31 d | 10-Q | $2.43B | +6.1% | $1.64 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 12, 2025 · pre-market | Feb 12, 2025 | 43 d | 10-K | $2.45B | +2.9% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 30, 2024 · pre-market | Oct 30, 2024 | 30 d | 10-Q | $2.47B | −2.5% | $2.66 | |
| Q2 2024 | Jun 30, 2024 | Aug 1, 2024 · pre-market | Aug 1, 2024 | 32 d | 10-Q | $2.46B | +0.4% | $4.00 | |
| Q1 2024 | Mar 31, 2024 | Apr 24, 2024 · pre-market | Apr 24, 2024 | 24 d | 10-Q | $2.29B | −7.0% | $2.70 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 13, 2024 · pre-market | Feb 14, 2024 | 45 d | 10-K | $2.39B | −6.2% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 · pre-market | Nov 8, 2023 | 39 d | 10-Q | $2.53B | +0.9% | -$0.47 | |
| Q2 2023 | Jun 30, 2023 | Jul 25, 2023 · pre-market | Jul 25, 2023 | 25 d | 10-Q | $2.46B | — | $4.07 | |
| Q1 2023 | Mar 31, 2023 | Apr 25, 2023 · pre-market | Apr 25, 2023 | 25 d | 10-Q | $2.46B | — | $2.67 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 15, 2023 · pre-market | Feb 15, 2023 | 46 d | 10-K | $2.54B | −6.9% | — | |
| Q3 2022 | Sep 30, 2022 | Oct 25, 2022 · pre-market | Oct 25, 2022 | 25 d | 10-Q | $2.51B | −9.7% | $7.84 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 3, 2022 · pre-market | Feb 3, 2022 | 34 d | 10-K | $2.73B | −4.2% | — | |
| Q3 2021 | Sep 30, 2021 | Oct 20, 2021 · pre-market | Oct 20, 2021 | 20 d | 10-Q | $2.78B | −17.7% | $2.22 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | Feb 3, 2021 · pre-market | Feb 3, 2021 | 34 d | 10-K | $2.85B | −22.3% | $2.32 | |
| Q3 2020 | Sep 30, 2020 | Oct 21, 2020 · pre-market | Oct 21, 2020 | 21 d | 10-Q | $3.38B | −6.2% | $4.46 | |
| Q2 2020 | Jun 30, 2020 | Jul 22, 2020 · pre-market | Jul 22, 2020 | 22 d | 10-Q | $3.68B | +1.8% | $9.59 | |
| Q1 2020 | Mar 31, 2020 | Apr 22, 2020 · pre-market | Apr 23, 2020 | 23 d | 10-Q | $3.53B | +1.3% | $8.08 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | Jan 30, 2020 · pre-market | Feb 6, 2020 | 37 d | 10-K | $3.67B | +4.1% | $8.08 | |
| Q3 2019 | Sep 30, 2019 | — | Oct 22, 2019 | 22 d | 10-Q | $3.60B | +4.7% | $8.39 | |
| Q2 2019 | Jun 30, 2019 | Jul 23, 2019 · pre-market | Jul 24, 2019 | 24 d | 10-Q | $3.62B | +7.8% | $7.85 | |
| Q1 2019 | Mar 31, 2019 | Apr 24, 2019 · pre-market | Apr 24, 2019 | 24 d | 10-Q | $3.49B | +11.5% | $7.15 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | Jan 29, 2019 · pre-market | Feb 6, 2019 | 37 d | 10-K | $3.53B | +6.6% | $4.73 | |
| Q3 2018 | Sep 30, 2018 | Oct 23, 2018 · pre-market | Oct 23, 2018 | 23 d | 10-Q | $3.44B | +11.7% | $7.15 | |
| Q2 2018 | Jun 30, 2018 | Jul 24, 2018 · pre-market | Jul 24, 2018 | 24 d | 10-Q | $3.36B | +9.0% | $4.18 | |
| Q1 2018 | Mar 31, 2018 | Apr 24, 2018 · pre-market | Apr 24, 2018 | 24 d | 10-Q | $3.13B | +11.4% | $5.54 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | Jan 25, 2018 · pre-market | Feb 1, 2018 | 32 d | 10-K | $3.31B | +15.1% | -$1.40 | |
| Q3 2017 | Sep 30, 2017 | — | Oct 24, 2017 | 24 d | 10-Q | $3.08B | +4.1% | $5.79 | |
| Q2 2017 | Jun 30, 2017 | — | Jul 25, 2017 | 25 d | 10-Q | $3.08B | +6.4% | $4.07 | |
| Q1 2017 | Mar 31, 2017 | — | Apr 25, 2017 | 25 d | 10-Q | $2.81B | +3.1% | $3.46 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Feb 2, 2017 | 33 d | 10-K | $2.87B | +1.2% | $2.99 | |
| Q3 2016 | Sep 30, 2016 | — | Oct 26, 2016 | 26 d | 10-Q | $2.96B | +6.4% | $4.71 | |
| Q2 2016 | Jun 30, 2016 | — | Jul 21, 2016 | 21 d | 10-Q | $2.89B | +11.7% | $4.79 | |
| Q1 2016 | Mar 31, 2016 | — | Apr 21, 2016 | 21 d | 10-Q | $2.73B | +6.7% | $4.43 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Feb 3, 2016 | 34 d | 10-K | $2.84B | +7.5% | $3.77 | |
| Q3 2015 | Sep 30, 2015 | — | Oct 21, 2015 | 21 d | 10-Q | $2.78B | +10.6% | $4.15 | |
| Q2 2015 | Jun 30, 2015 | — | Jul 24, 2015 | 24 d | 10-Q | $2.59B | +7.0% | $3.93 | |
| Q1 2015 | Mar 31, 2015 | — | Apr 24, 2015 | 24 d | 10-Q | $2.56B | +20.0% | $3.49 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | Feb 4, 2015 | 35 d | 10-K | $2.64B | +34.3% | $3.74 | |
| Q3 2014 | Sep 30, 2014 | — | Oct 22, 2014 | 22 d | 10-Q | $2.51B | +37.4% | $3.62 | |
| Q2 2014 | Jun 30, 2014 | — | Jul 23, 2014 | 23 d | 10-Q | $2.42B | +40.5% | $3.01 | |
| Q1 2014 | Mar 31, 2014 | — | Apr 23, 2014 | 23 d | 10-Q | $2.13B | +50.5% | $2.02 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | — | — | — | $1.97B | +38.6% | $1.92 | |
| Q3 2013 | Sep 30, 2013 | — | Oct 28, 2013 | 28 d | 10-Q | $1.83B | +31.9% | $2.05 | |
| Q2 2013 | Jun 30, 2013 | — | Jul 25, 2013 | 25 d | 10-Q | $1.72B | +21.3% | $2.06 | |
| Q1 2013 | Mar 31, 2013 | — | Apr 25, 2013 | 25 d | 10-Q | $1.42B | +9.5% | $1.79 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | — | — | — | $1.42B | +6.9% | $1.23 | |
| Q3 2012 | Sep 30, 2012 | — | Oct 25, 2012 | 25 d | 10-Q | $1.39B | +5.8% | $1.67 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $1.42B | +17.6% | $1.61 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $1.29B | +7.4% | $1.25 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2011 | — | — | — | — | $1.33B | +8.8% | $1.22 | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $1.31B | +11.4% | $1.43 | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $1.21B | −0.3% | $1.18 | |
| Q1 2011 | Mar 31, 2011 | — | Apr 21, 2011 | 21 d | 10-Q | $1.20B | +8.5% | $1.20 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010 | Dec 31, 2010 | — | — | — | — | $1.22B | +8.2% | $0.99 | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $1.18B | +4.9% | $1.05 | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $1.21B | +10.9% | $1.12 | |
| Q1 2010 | Mar 31, 2010 | — | Apr 20, 2010 | 20 d | 10-Q | $1.11B | +7.0% | $0.80 | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009 | Dec 31, 2009 | — | — | — | — | $1.13B | — | $1.06 | |
| Q3 2009 | Sep 30, 2009 | — | Oct 21, 2009 | 21 d | 10-Q | $1.12B | +2.5% | $0.95 | |
| Q2 2009 | Jun 30, 2009 | — | Jul 17, 2009 | 17 d | 10-Q | $1.09B | +10.1% | $0.49 | |
| Q1 2009 | Mar 31, 2009 | — | — | — | — | $1.04B | — | $0.84 | |
| FY 2008 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2008derived | Dec 31, 2008 | — | — | — | — | — | — | — | |
| Q3 2008 | Sep 30, 2008 | — | — | — | — | $1.09B | — | $0.70 | |
| Q2 2008 | Jun 30, 2008 | — | — | — | — | $993.44M | — | $0.70 | |
